Funding Rounds
NMD Pharma

NMD Pharma Series B (2023, $81M)

NMD Pharma

Treatment for severe neuromuscular disorders.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $81.61M

Investors